Status:
COMPLETED
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Alaska Native Medical Center
Conditions:
Hepatitis
Eligibility:
All Genders
5-14 years
Brief Summary
The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
Detailed Description
Routine hepatitis B vaccination beginning at birth was provided to Alaska Natives several years before other areas of the United States began routine infant hepatitis B vaccination programs. Follow up...
Eligibility Criteria
Inclusion
- Received 3 doses of hepatitis B vaccine during infancy, beginning at birth
Exclusion
- Mother HBsAg-positive immunosuppressed
Key Trial Info
Start Date :
May 1 2001
Trial Type :
OBSERVATIONAL
End Date :
March 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00141999
Start Date
May 1 2001
End Date
March 1 2008
Last Update
September 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alaska Native Medical Center
Anchorage, Alaska, United States, 99508